[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Anti - Restenosis Therapy
You may be aware that there are two approaches being developed to
irradiate arteries (primarily coronary) to prevent restenosis. Both
approaches are designed to deliver somewhere around 20 Gray to some
point within the arterial wall ... exact target tissue is being
debated.
1. The first approach carries with it very little radiation safety
baggage, that being an arterial stent which is coated with around
0.5-2.0 microcuries of P-32 -- left permanently in place it de-
livers the desired 20 Gy over a period of weeks. Although not
final, we're considering treating this procedure, although thera-
peutic, in a manner similar to the way we (and NRC) are treating
the C-14 urea pyloric ulcer breath test; staying out of the way).
2. The second approach, in essence, utilizes a high-dose rate, remote
control brachytherapy device (HDR/RCB; maybe 100 mCi P-32), snaked
into the area of stenosis by a physician qualified to perform
cardiac catheterization -- the rub here, is that physicians quali-
fied to use radioactive material usually aren't qualified to perform
cardiac catheterization; and vice versa. Therefore, it looks as
though a cardiac cath doc will use an IntraVascular Brachytherapy
(IVB) HDR/RCB to place the source within the area of stenosis for
about 5 minutes (whatever is necessary to deliver the desired dose).
The traditional team for HDR/RCBs is also going to have to be
involved: Physicists for dose planning; RSO for radiation safety;
and an Authorized Physician User of HDR/RCB to (1) evaluate potential
patient complications which may evolve from the combination of high
dose rate radiation and other existing patient conditions (e.g.,
previous radiation exposures); and (2) order and supervise the use
of the radioactive material.
I, likewise, would be interested in any experiences from the real world.
Pete.
Date: Wed, 11 Feb 1998 13:38:05 -0600 (CST)
Reply-to: radsafe@romulus.ehs.uiuc.edu
From: "Dale E. Boyce" <dale@radpro.uchicago.edu>
To: Multiple recipients of list <radsafe@romulus.ehs.uiuc.edu>
Subject: Anti - Restenosis Therapy
I am interested in hearing feedback from any of you that have
folks doings interventional treatments employing radioactive material to
irradiate coronary arteries to prevent restenosis. Our place is
thinking about doing it, and I'd like to hear how it's going from
a radiation safety standpoint elsewhere. Especially if there are any
problems.
Dale Boyce
dale@radpro.uchicago.edu
Pete Myers, Cf, Med & Acad Licensing
Bureau Rad Control, Texas Dept Hlth
Phone (512) 834-6688 (FAX 834-6690)
Pete.Myers@tdh.state.tx.us